Bristol Myers Squibb in the news
ShareCopied to clipboardAnalyze the latest Bristol Myers Squibb news, with a current slightly positive sentiment polarity (0.36) or the entire set.
Latest news
Here are the latest news on this scope:
Bristol Myers Squibb tops quarterly estimates, hikes outlook as drugmaker braces for tariffs
Stocks making the biggest moves after hours: Tesla, Enphase Energy, Oklo, Bristol Myers Squibb and more
Bristol Myers Squibb plans $2 billion in cost cuts by 2027, issues weak guidance
Bristol Myers Squibb says Alzheimer's is the biggest market for new schizophrenia drug
Bristol Myers Squibb tops earnings estimates and hikes outlook, helped by Eliquis and new drugs
Bristol Myers Squibb beats earnings estimates, raises outlook as drugmaker slashes costs
Bristol Myers Squibb Cancer-Treatment Trial Misses Endpoint
Judge tosses Medicare drug negotiation challenges from Bristol Myers Squibb, Johnson & Johnson
Judge rejects J&J, Bristol Myers Squibb challenges to Medicare drug-price negotiations
Bristol Myers Squibb beats on revenue, launches $1.5 billion cost cuts as it posts quarterly loss
Bristol Myers Squibb drafts contingency plans for US restrictions on Chinese pharma
Healthy Returns: J&J cell therapy gains new edge over Bristol Myers rival
J&J, Merck and Bristol Myers Squibb CEOs Defend Drug Prices at Senate Hearing
Bristol Myers Squibb results top estimates as new drugs post strong sales growth
Healthy Returns: J&J, Merck and Bristol Myers Squibb are in the hot seat
Stocks making the biggest moves midday: Nike, Rocket Lab, Bristol Myers, NetEase and more
Stocks making the biggest moves before the bell: Nike, Bristol Myers, NetEase, Coinbase, and more
Bristol Myers Squibb to Discontinue Metastatic Colorectal Cancer Trial
Extract data
Extract all the news on this scope:
Visualize data
Here are some available charts on these news:
Evolution through time
Distribution of sources in the news
Distribution of sections in the news
Sentiment polarity through time